Intrinsic Value of S&P & Nasdaq Contact Us

NexImmune, Inc. NEXI OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
65/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.33
+3329900%

NexImmune, Inc. (NEXI) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold.

The consensus price target is $3.33 (low: $2.00, high: $5.00), representing an upside of 3329900% from the current price $0.00.

NEXI Stock — 12-Month Price Forecast

$3.33
▲ +3,329,900.00% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for NexImmune, Inc., the average price target is $3.33, with a high forecast of $5.00, and a low forecast of $2.00.
The average price target represents a +3,329,900.00% change from the last price of $0.00.
Highest Price Target
$5.00
Average Price Target
$3.33
Lowest Price Target
$2.00

NEXI Analyst Ratings

Buy
4
Ratings
2 Buy
2 Hold
Based on 4 analysts giving stock ratings to NexImmune, Inc. in the past 3 months
Rating breakdown
Buy
2 50%
Hold
2 50%
50%
Buy
2 analysts
50%
Hold
2 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message